Organon & Co. (OGN)
Organon Market Cap : 3.528B for May 20, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Merck & Co., Inc. | 279.76B |
| Eli Lilly & Co. | 898.38B |
| Ligand Pharmaceuticals, Inc. | 4.362B |
| Veradermics, Inc. | 4.375B |
| Johnson & Johnson | 553.59B |
Market Cap Related Metrics
| PE Ratio | 14.31 |
| PS Ratio | 0.5689 |
| Price to Book Value | 3.907 |
| Price to Free Cash Flow | 4.952 |
| Price | 13.44 |
| Earnings Yield | 6.99% |
| Operating PE Ratio | 2.941 |
| Normalized PE Ratio | 7.870 |